• SB 202190: p38 MAP Kinase Inhibitor Workflows

  2026-09-29

  SB 202190 enables timed, reversible inhibition of p38α/β to separate inflammatory, apoptotic, and growth signals in cell-based assays. This workflow-focused guide shows how to pair the compound with phospho-readouts, secretion assays, and pathway controls while avoiding common solubility and interpretation errors.

• Astrocyte–Microglia Crosstalk in 2-CE Neuroinflammation

  2026-09-28

  The reference study proposes that astrocytes, rather than microglia, are the early cellular responders to 2-chloroethanol, an intermediate metabolite of 1,2-dichloroethane. Its main contribution is a mechanistic link between ROS-driven p38 MAPK/NF-κB and AP-1 activation in A1 astrocytes and subsequent M1-like microglial polarization through astrocyte-derived inflammatory mediators.

• Tetraethylammonium Chloride: Interpreting K+ Blockade

  2026-09-28

  Tetraethylammonium chloride (TEAC) is a useful probe of potassium-channel conduction, but its effects require careful interpretation. This article connects TEAC-based experiments to β-cell channel research and shows how orthogonal readouts can strengthen mechanistic conclusions without treating distinct blockers as interchangeable.

• SR 11302 for AP-1 Inhibitor Assays

  2026-09-27

  A scenario-based guide to using SR 11302 (AP-1 transcription factor inhibitor), SKU A8185, in cell-proliferation and cancer-mechanism studies. It covers model selection, formulation, interpretation, and practical supplier checks while distinguishing product information from evidence in a macrophage-signaling study.

• CDK4, 4E-BP1, and Translation at Mitosis–G1

  2026-09-26

  The study examines how CDK4 regulates the translational repressor 4E-BP1 as cells move from mitosis into G1, extending evidence that CDK4 can support cap-dependent translation beyond its established role in cell-cycle control. Its findings frame translation as a cell-cycle-regulated process and suggest that CDK4 activity may complement mTORC1 in controlling 4E-BP1, with implications for interpreting translation pathways in cancer research.

• Candida krusei Morphotypes Trigger Distinct BMEC Apoptosis

  2026-09-25

  Miao and colleagues found that both yeast- and hypha-phase Candida krusei induce apoptosis in bovine mammary epithelial cells, but with different dominant signaling routes: mitochondrial signaling for yeast and death ligand/receptor signaling for hyphae. Their co-culture study also implicates TLR2/ERK and JNK/ERK signaling, providing a mechanistic framework for investigating fungal mastitis and epithelial injury.

• SP600125 for JNK Signaling: Assays and Workflows

  2026-09-25

  Use SP600125 to test whether JNK activity contributes to stress responses, c-Jun phosphorylation, or cytokine changes—without confusing JNK inhibition with the ERK mechanism identified in a recent nanoplastics study. This workflow pairs practical dose selection and controls with orthogonal readouts for stronger pathway interpretation.

• DAPI (hydrochloride): Practical Staining Guide

  2026-09-24

  DAPI (hydrochloride) provides fluorescent DNA labeling for microscopy, chromosome staining, histochemistry, and flow-cytometric DNA-content workflows. It is suitable for fixed cells and, with concentration optimization, live cells; it is not a sequence-specific assay or a substitute for validated viability and cell-cycle controls.

• Click-Compatible BmTyr Maps T-Cell Proteomes

  2026-09-24

  The study introduces a copper-dependent BmTyr proximity-labeling platform that uses an alkyne-phenol probe and click chemistry to profile subcellular proteins without relying on biotin. In primary T cells, it supports proteomic enrichment and antibody-independent validation, and it links NKAP with a previously unappreciated chromatin-associated localization.

• TAK-715: Designing Better p38 MAPK Inhibition Assays

  2026-09-23

  TAK-715 is a potent p38 MAPK inhibitor for investigating p38α-dependent inflammatory signaling. This article goes beyond compound selection to show how to distinguish catalytic inhibition, activation-loop dephosphorylation, and downstream cytokine effects in a rigorous assay design.

• Tetraethylammonium Chloride: A Causal K+ Probe

  2026-09-23

  Tetraethylammonium chloride (TEAC) is more than a potassium channel blocker: it is a useful causal perturbation for separating pore conduction from receptor signaling. This guide connects TEAC assay design with the landmark β-cell K+ channel study and vascular research applications.

• JNK-IN-7 for Apoptosis and JNK Signaling Assays

  2026-09-22

  JNK-IN-7 provides a selective, covalent route to test whether JNK activity contributes to c-Jun phosphorylation, inflammation, and apoptosis. This workflow adapts phase-resolved Candida krusei infection findings into practical host-cell experiments while emphasizing concentration control, matched controls, and pathway-specific interpretation.

• M. tuberculosis WecA: Purification and Kinetic Analysis

  2026-09-22

  The 2026 reference study establishes a regulated expression and purification workflow for the difficult 11-transmembrane Mycobacterium tuberculosis enzyme WecA. By combining Lemo21(DE3) expression, affinity purification, mass-spectrometric identification, and UMP-based activity analysis, the authors show that tunicamycin inhibits WecA competitively and provide a practical foundation for inhibitor discovery.

• Stable Yeast Expression of Exendin-4 for Type 2 Diabetes

  2026-09-21

  The 2024 study developed recombinant Exendin-4 expression models in Escherichia coli and Saccharomyces cerevisiae, demonstrating Exendin-4 production from a chromosomally integrated yeast strain by size analysis and immunoassay. The work establishes an important manufacturing proof of concept for locally propagated GLP-1 receptor agonist production, while leaving biological activity, purification, dosing, and oral delivery for future investigation.

• Tetraethylammonium chloride in K+ Channel Assays

  2026-09-21

  Tetraethylammonium chloride (TEAC) converts K+ channel blockade into a practical probe for pore access, ion conduction, pancreatic β-cell physiology, and vascular responses. This workflow-focused guide connects electrophysiology, 86Rb efflux, insulin-release experiments, and troubleshooting strategies while separating direct evidence from recommended starting conditions.

8618 records 1/575 page Next 12345 下5页 Last page